Literature DB >> 2591422

Pharmacokinetic and nephrotoxic study of gentamicin in rabbits using a new dosage regimen.

M A Trapote1, M A Arévalo, J M Lanao, M G Macias, A S Navarro, M J Alonso, M L Sayalero, A Domínguez-Gil.   

Abstract

Currently, in certain clinical situations there is an increasing trend towards using dosage regimens involving aminoglycoside antibiotics based on the administration of a single dose of the drug per day instead of administering the same amount in two or three administrations. The aim of the present study was to discover the pharmacokinetic profile and the nephrotoxic potential of this new form of administration in experimental animals receiving gentamicin. The study was conducted on two groups of rabbits, one of which received a single dose of the drug at 7 mg/kg i.v. and the other 7 mg/kg administered every 12 hours, allometrically equivalent to gentamicin dosing at 5 mg/kg every 24 hours to human subjects. The number of doses administered was 20. From the pharmacokinetic point of view, the results point to the existence of a significant degree of accumulation of the antibiotic in renal cortex as a result of the dosage regimen, no important modifications occurring in the pharmacokinetic parameters of gentamicin calculated from its plasma kinetics. This shows that the two compartment model employed predicts drug levels in accessible tissues but not in deep ones where gentamicin is accumulated for long periods of time. From the toxicological point of view, the treatment caused appreciable damage of the renal tubules during the first phases of the treatment which was not detectable from the serum creatinine levels or the kinetic behaviour of the aminoglycoside.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2591422     DOI: 10.1007/BF03190858

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  11 in total

1.  Distribution of gentamicin and amikacin in rabbit tissues.

Authors:  M L Kornguth; C M Kunin
Journal:  Antimicrob Agents Chemother       Date:  1977-06       Impact factor: 5.191

2.  NONLIN84/PCNONLIN: software for the statistical analysis of nonlinear models.

Authors:  D L Weiner
Journal:  Methods Find Exp Clin Pharmacol       Date:  1986-10

3.  Nephrotoxicity of gentamicin.

Authors:  J C Kosek; R I Mazze; M J Cousins
Journal:  Lab Invest       Date:  1974-01       Impact factor: 5.662

Review 4.  The nephrotoxicity of antimicrobial agents (first of three parts).

Authors:  G B Appel; H C Neu
Journal:  N Engl J Med       Date:  1977-03-24       Impact factor: 91.245

5.  Statistical moments in pharmacokinetics.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

6.  A light and electron microscopic analysis of gentamicin nephrotoxicity in rats.

Authors:  D C Houghton; M Hartnett; M Campbell-Boswell; G Porter; W Bennett
Journal:  Am J Pathol       Date:  1976-03       Impact factor: 4.307

7.  Predictability of blood levels of gentamicin in man.

Authors:  M Barza; R B Brown; D Shen; M Gibaldi; L Weinstein
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

8.  Gentamicin-induced loss of basolateral surface area of rat proximal convoluted tubules.

Authors:  D B Jones; W C Elliott
Journal:  Lab Invest       Date:  1987-10       Impact factor: 5.662

9.  A model for dosing gentamicin in children and adolescents that adjusts for tissue accumulation with continuous dosing.

Authors:  W E Evans; R H Taylor; S Feldman; W R Crom; G Rivera; G C Yee
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

10.  Controlled comparison of gentamicin and tobramycin nephrotoxicity.

Authors:  G R Matzke; R L Lucarotti; H S Shapiro
Journal:  Am J Nephrol       Date:  1983 Jan-Feb       Impact factor: 3.754

View more
  1 in total

1.  Influence of dose on the disposition kinetics of netilmicin in the isolated kidney of the rat.

Authors:  Aránzazu Zarzuelo; Amparo Sánchez-Navarro; Francisco G López; José M Lanao
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2002 Apr-Jun       Impact factor: 2.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.